PhillyPharma Archive: January, 2012

Pfizer slumps in fourth quarter, 2011

Comment icon 0 Comments
Pfizer, the global pharmaceutical giant with operations in the Philadelphia region, reported operational revenue declines for the fourth quarter... Read more

Neglected tropical diseases get attention

Comment icon 0 Comments
Neglected tropical diseases got very high-profile attention Monday morning when the World Health Organization, nine global pharmaceutical companies... Read more

Teva's Cephalon recalls 1 lot of injectable leukemia drug Treanda

Comment icon 0 Comments
Teva Pharmaceuticals' subsidiary Cephalon said Friday that it had issued a recall in November for one lot of the injectable leukemia drug Treanda... Read more

James Murdoch to leave GSK board of directors

Comment icon 0 Comments
With a phone hacking scandal still raging or smoldering, depending on the moment, James Murdoch - son of media baron Rupert Murdoch - will... Read more

State of the Union speech.....and Synthes?

Comment icon 0 Comments
Regardless of the president or his party, modern State of the Union speeches are weeks in the making and all the federal agencies push to have... Read more

J&J-Weldon bet on Synthes assumes more elective surgery

Comment icon 0 Comments
In the United States, if you are rushed to the hospital with broken bones, trauma surgery is likely to occur, whether you can pay for it... Read more

McNeil's Fort Washington plant won't resume production until 2013

Comment icon 0 Comments
Johnson & Johnson chief executive officer Bill Weldon said Tuesday morning that the McNeil Consumer Healthcare plant in Fort Washington... Read more

J&J officials scheduled to discuss company outlook Tuesday

Comment icon 0 Comments
Johnson & Johnson Chief Executive Officer Bill Weldon and other top officials are scheduled to report yearly results for 2011 and fourth-quarter... Read more